• Webcast
    Q2 2018 Clovis Oncology, Inc. Earnings Conference Call
    Wednesday, August 1, 2018 04:30 PM EDT

Corporate Profile

Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Clovis’ development programs are targeted at specific subsets of cancer, combining precision medicine with companion diagnostics to direct therapeutics to those patients most likely to benefit from their use. Clovis believes this approach to precision medicine – to deliver the right drMore >>

Stock Chart

Stock Quote

Copyright Nasdaq. Minimum 15 minutes delayed.